Pluristem Therapeutics

Preliminary Data from Pluristem’s PLC Cell Program Shows Promise in COVID-19
BioSpace
Thu, 04/9/20 - 11:29 pm
COVID-19
Pluristem Therapeutics
PLC cell program
ARDS
Pluristem Reports Positive Top-Line PhII Results From Its Placenta Derived Cell Therapy In Peripheral Artery Disease
Tue, 06/12/18 - 10:04 am
Pluristem Therapeutics
intermittent claudication
Pluristem's Clinical Advisory Board Prepares Phase II Clinical Trials in Critical Limb Ischemia in Europe and Japan
Yahoo
Mon, 04/20/15 - 10:32 am
Pluristem Therapeutics
critical limb ischemia
Europe
Japan
Pluristem Therapeutics submits FDA orphan drug application for PLX-PAD
The Fly on the Wall
Thu, 02/20/14 - 08:14 am
FDA
orphan drugs
Pluristem Therapeutics
PLX-PAD
preeclampsia
Pluristem's Positive Data Could Open Massive Muscle Injury Market
Seeking Alpha
Tue, 01/7/14 - 09:24 am
Pluristem Therapeutics
Stryker
JNJ
Zimmer
hip recall
PLX cell therapy
Top Biotech Stock Picks for Q4 2013: An Interview with the Senior Analyst at Oppenheimer & Company
Yahoo/Wall St Transcript
Sat, 09/14/13 - 10:38 am
Amgen
Celgene
ONYX Pharmaceuticals
Keryx
Pluristem Therapeutics
NPS Pharmaceuticals
Pluristem Granted Key U.S. Patent for the Treatment of Peripheral Artery Disease
Yahoo
Wed, 09/11/13 - 11:28 am
Pluristem Therapeutics
peripheral artery disease
placental-based cells
United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy
Seeking Alpha
Tue, 04/30/13 - 08:37 am
United Therapeutics
PAH
pulmonary arterial hypertension
Remodulin
Pluristem Therapeutics
3 Healthcare Stock Stories For Weekend Investment Wellness
Wall Street Cheat Street
Sat, 04/20/13 - 11:04 am
Pluristem Therapeutics
Vertex Pharmaceuticals
Chembio Diagnostics
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sun, 12/30/12 - 12:07 pm
Medifast
Questcor Pharmaceuticals
Pluristem Therapeutics
Are Short-Sellers Onto Something at Pluristem Therapeutics?
Motley Fool
Sun, 12/2/12 - 11:49 am
Pluristem Therapeutics
This Week in Biotech: Part 2
Motley Fool
Sun, 11/11/12 - 09:19 am
Biocryst
Catalyst Pharmaceutical Partners
Pluristem Therapeutics
Vivus
Arena Pharmaceuticals
Eisai
Pluristem Wants Bloomberg Retraction, Array Sets Secondary: Healthcare Business Wrap
Wall St Cheat Street
Sat, 11/10/12 - 08:23 am
Pluristem Therapeutics
Array Biopharma
5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments
Seeking Alpha
Tue, 10/9/12 - 04:21 pm
PLX
Pluristem Therapeutics
Ariad Pharmaceuticals
Ponatinib
Sarepta
eteplirsen
Fabry's disease
Amicus Therapeutics
StemCells
Interim Data In Spinal Cord Injury Driving STEM Higher; PSTI Reacting in Sympathy
Yahoo/Reuters
Tue, 09/4/12 - 11:51 am
StemCells
Pluristem Therapeutics
human neural stem cells
spinal cord injury
Healthcare Biz Recap: Vivus’ PATENT Problem, Idenix Survives Clinical HOLD
Wall Street Cheat Street
Sat, 08/18/12 - 03:48 pm
Vivus
generics
Qsymia
Idenix
Pluristem Therapeutics
4 Pharmaceutical Companies Moving On News
Seeking Alpha
Mon, 08/6/12 - 11:13 am
Oxigene
Biostar Pharmaceuticals
Pluristem Therapeutics
Cellceutix
One Stock To Buy, Two Avoids, And A Swing Trade From Last Week's Big Biotech News Movers
Seeking Alpha
Sat, 07/21/12 - 11:48 am
StemCells
Astex
Pluristem Therapeutics
ONYX Pharmaceuticals
Vivus
Pluristem Therapeutics' Answer To Big Pharma's Question: What Do We Do Now?
Seeking Alpha
Wed, 07/18/12 - 12:27 pm
Pluristem Therapeutics
Alkermes
AstraZeneca
Bristol-Myers Squibb
Isis Pharmaceuticals
Eli Lilly
Momenta
Merck
Pfizer
Sanofi
Spectrum Pharmaceuticals
2 Pharma Plays Trading Under $2 For The Aggressive Investor
Seeking Alpha
Sun, 07/1/12 - 12:05 pm
Pluristem Therapeutics
PharmAthene